Pierre Michel Jean Beltran
About Pierre Michel Jean Beltran
Pierre Michel Jean Beltran is a Postdoctoral Fellow at the Broad Institute of MIT and Harvard, specializing in proteomics and computational biology. He has a background in Molecular Biology from Princeton University and has previously worked at institutions such as Caltech and Rochester Institute of Technology.
Work at Broad Institute
Currently, Pierre Michel Jean Beltran serves as a Postdoctoral Fellow at the Broad Institute of MIT and Harvard. He has held this position since 2018 in the Greater Boston Area. His research focuses on developing and applying proximity-labeling proteomic technologies to study inter-organ communication. He also engages in projects related to infectious diseases, exercise biology, and cancer, aiming to uncover novel drug targets and therapeutics.
Education and Expertise
Pierre Beltran has an extensive educational background in molecular biology and biotechnology. He earned a Doctor of Philosophy (Ph.D.) in Molecular Biology from Princeton University, where he studied from 2012 to 2018. Prior to that, he obtained a Master of Arts (M.A.) in Molecular Biology from Princeton University in 2013. He also holds a Bachelor's Degree in Biotechnology/Molecular Biosciences with a Bioinformatics Option from the Rochester Institute of Technology, completed in 2012.
Background in Research
Pierre Beltran has a diverse research background, having worked in various capacities at notable institutions. He was a Research Assistant at Caltech for three months in 2012 and a Research Fellow there for another three months in 2011. At the Rochester Institute of Technology, he served as a Lab Technician from 2010 to 2012 and as an Undergraduate Research Assistant from 2009 to 2012. His experiences have contributed to his expertise in bridging proteomics technology with computational and statistical approaches.
Achievements in Molecular Biology
Throughout his career, Pierre Beltran has focused on integrating large biological datasets to address biological problems. His work emphasizes understanding the molecular mechanisms underlying the health benefits of physical activity through proteomic technologies. He has contributed to research projects that explore infectious diseases, exercise biology, and cancer, demonstrating his commitment to advancing knowledge in these critical areas.